LETTER
Immunosuppressive Effect of Zidovudine
Edward K. Chapnick;
Douglas V. Sepkowitz; and
Jeremy D. Gradon
1 April 1993 | Volume 118 Issue 7 | Pages 571-572
TO THE EDITOR:
We read McLeod and Hammer's review [1] on zidovudine with great interest. The authors state that there has been one reported case of zidovudine-induced hepatitis [2]. We wish to call to your readers' attention another case, which we reported in 1992 [3], further emphasizing the need to consider this agent in the differential diagnosis of hepatitis in HIV-infected patients.
1. McLeod GX, Hammer SM. Zidovudine: five years later. Ann Intern Med. 1992; 117:487-501.
2. Dubin G, Braffman MN. Zidovudine-induced hepatotoxicity. Ann Intern Med. 1989; 110:85-6.
3. Gradon JD, Chapnick EK, Sepkowitz DV. Case report. Zidovudine-induced hepatitis. J Intern Med. 1992; 231:317-8.
About Letters
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
Top
References
Article
